Home › Funds › Geode Capital Management › BCAX
Geode Capital Management position in BCAX
BICARA THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1.16M sh
Reported value held$34.53M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 48.64K | $1.24M | New |
| Q4 2024 | 466.64K | $8.13M | Add |
| Q1 2025 | 491.65K | $6.41M | Add |
| Q2 2025 | 672.49K | $6.25M | Add |
| Q3 2025 | 831.21K | $13.13M | Add |
| Q4 2025 | 811.40K | $13.66M | Reduce |
| Q1 2026 | 830.91K | $16.53M | Add |
| Q2 2026 | 1.16M | $34.53M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BCAX
- BlackRock Inc 3.85M sh · $114.25M · Q2 2026
- Janus Henderson Group 3.33M sh · $66.11M · Q1 2026
- Franklin Resources 1.95M sh · $57.95M · Q2 2026
- Fidelity Management & Research (FMR) 1.89M sh · $56.21M · Q2 2026
- Vanguard Group 2.19M sh · $36.79M · Q4 2025
- JPMorgan Chase & Co 1.02M sh · $29.81M · Q2 2026
- Goldman Sachs Group 520.57K sh · $15.46M · Q2 2026
- D. E. Shaw & Co 498.19K sh · $14.79M · Q2 2026
- Northern Trust Corp 396.34K sh · $11.77M · Q2 2026
- Charles Schwab Investment Management 365.48K sh · $10.85M · Q2 2026
- Bank of America Corp 352.90K sh · $10.48M · Q2 2026